Investors

Insider Transactions

Date Name Title Type Shares Traded Price Range
Feb 11, 2014 gilman alfred g Director Automatic Sell 5,000 320.00
Feb 11, 2014 gilman alfred g Director Option Execute 5,000 18.61
Feb 11, 2014 mccorkle douglas s Officer Automatic Sell 5,819 325.00
Feb 11, 2014 mccorkle douglas s Officer Option Execute 5,819 30.63
Feb 11, 2014 vagelos p roy Officer Automatic Sell 11,475 325.10
Feb 11, 2014 yancopoulos george Officer Automatic Sell 100,476 314.31
Feb 11, 2014 yancopoulos george Officer Option Execute 189,463 9.49
Feb 7, 2014 sanofi Beneficial Owner (10% or more) Buy 21,986 284.49 - 289.98
Feb 6, 2014 sanofi Beneficial Owner (10% or more) Buy 146,525 282.84 - 287.88
Feb 5, 2014 sanofi Beneficial Owner (10% or more) Buy 206,978 274.64 - 288.13
Feb 4, 2014 sanofi Beneficial Owner (10% or more) Buy 190,286 282.05 - 287.78
Feb 3, 2014 sanofi Beneficial Owner (10% or more) Buy 198,058 279.14 - 289.62
Jan 31, 2014 sanofi Beneficial Owner (10% or more) Buy 10,914 286.13 - 289.90
Jan 28, 2014 sanofi Beneficial Owner (10% or more) Buy 83,235 273.44 - 279.26
Jan 27, 2014 sanofi Beneficial Owner (10% or more) Buy 74,685 269.77 - 275.31
Jan 14, 2014 gilman alfred g Director Automatic Sell 5,000 300.00
Jan 14, 2014 gilman alfred g Director Option Execute 5,000 18.61
Jan 14, 2014 mccorkle douglas s Officer Automatic Sell 4,000 290.00
Jan 10, 2014 vagelos p roy Officer Disposition (Non Open Market) 764 n/a
Jan 2, 2014 powchik peter Officer Automatic Sell 20,668 272.88 - 277.50
Showing 321-340 of 1040 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)